Free-Living Motor Activity Monitoring in Ataxia-Telangiectasia
- 24 July 2021
- journal article
- research article
- Published by Springer Nature in The Cerebellum
- Vol. 21 (3) , 368-379
Abstract
With disease-modifying approaches under evaluation in ataxia-telangiectasia and other ataxias, there is a need for objective and reliable biomarkers of free-living motor function. In this study, we test the hypothesis that metrics derived from a single wrist sensor worn at home provide accurate, reliable, and interpretable information about neurological disease severity in children with A-T. A total of 15 children with A-T and 15 age- and sex-matched controls wore a sensor with a triaxial accelerometer on their dominant wrist for 1 week at home. Activity intensity measures, derived from the sensor data, were compared with in-person neurological evaluation on the Brief Ataxia Rating Scale (BARS) and performance on a validated computer mouse task. Children with A-T were inactive the same proportion of each day as controls but produced more low intensity movements (p < 0.01; Cohen’s d = 1.48) and fewer high intensity movements (p < 0.001; Cohen’s d = 1.71). The range of activity intensities was markedly reduced in A-T compared to controls (p < 0.0001; Cohen’s d = 2.72). The activity metrics correlated strongly with arm, gait, and total clinical severity (r: 0.71–0.87; p < 0.0001), correlated with specific computer task motor features (r: 0.67–0.92; p < 0.01), demonstrated high reliability (r: 0.86–0.93; p < 0.00001), and were not significantly influenced by age in the healthy control group. Motor activity metrics from a single, inexpensive wrist sensor during free-living behavior provide accurate and reliable information about diagnosis, neurological disease severity, and motor performance. These low-burden measurements are applicable independent of ambulatory status and are potential digital behavioral biomarkers in A-T.Keywords
Funding Information
- University of Pennsylvania Orphan Disease Center
- A-T Children's Project
- Biogen
This publication has 36 references indexed in Scilit:
- Improved ALS clinical trials through frequent at‐home self‐assessment: a proof of concept studyAnnals of Clinical and Translational Neurology, 2020
- mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson’s diseasenpj Digital Medicine, 2020
- Quantifying neurologic disease using biosensor measurements in-clinic and in free-living settings in multiple sclerosisnpj Digital Medicine, 2019
- Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor DevicesDigital Biomarkers, 2019
- Design and results of a smartphone‐based digital phenotyping study to quantify ALS progressionAnnals of Clinical and Translational Neurology, 2019
- Ataxia telangiectasia: a reviewOrphanet Journal of Rare Diseases, 2016
- Evaluating more naturalistic outcome measuresNeurology Neuroimmunology & Neuroinflammation, 2015
- Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical TrialsPLOS ONE, 2015
- Ataxia telangiectasia2015
- Current and potential therapeutic strategies for the treatment of ataxia-telangiectasiaBritish Medical Bulletin, 2007